In a previous study, we determined that prior to treatment with anti-TNFα, non-responder RA patients had high frequencies of IL-17+ T cells and, when their T cells stimulated in vitro, the cells produced significantly higher levels of IL-17 than responder patients [12]. This evidence concerns the gene IL17A and rheumatoid arthritis.